The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA,1 and Centre for Molecular Microbiology and Infection, Imperial College, London SW7 2AZ,2 United Kingdom
*Corresponding author. Phone: +44 (0) 1223 494828, Fax: +44 (0)1223 494919, E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
The bacterial factors responsible for an invasive phenotype in humans are not known. Genetic comparisons of the different serotypes, including plasmid carriage (70), have given some clues as to which genes might be required for systemic spread in the human host (Table 2). However, the regulation of these genes may also be important and, as yet, few studies have compared the expression of known virulence determinants in the different serotypes.
Serotype Typhi causes typhoid fever, which is the most common form of enteric fever; it was first described by both Eberth and Koch in 1880 and subsequently cultured by Gaffki in 1884. Agglutination with specific sera and the ability to ferment sugars allows serotype Typhi to be differentiated from nonpathogenic Escherichia coli. An inverse relationship between pathogenicity and the ability to ferment sugars has been described, with isolates from food poisoning being intermediate in both respects. Isolates resembling the food-poisoning bacteria have also been isolated from cases of enteric fever but these can be differentiated from other enteric-fever-causing organisms by culture on lead acetate media. These isolates were termed "B. paratyphosus" (93). An improved form of the lead acetate test is still in use (2, 52).
Enteric fever is a febrile, systemic illness. Fever itself is the only consistent symptom (63), although abdominal pain or discomfort, muscle and/or joint pain, and headache are frequently observed. All these resolve relatively quickly if a course of an appropriate antibiotic is administered, but they can persist for several weeks in the untreated patient (63). Some typhoid patients develop complications (21), the most severe of which is gastrointestinal (GI) hemorrhage and perforation (12, 23), a condition requiring both surgical and antimicrobial intervention and which carries a high risk of mortality (11). A minority of infected persons become asymptomatic chronic carriers and continue to intermittently excrete serotype Typhi in their stools for prolonged periods (>1 year).
Serotype Typhi is restricted and adapted to the human host. It is identified by its serotype, O9 [Vi]: Hd, and specific biochemical reactions. It is less sacchrolytic than most other members of the S. enterica species and forms a discrete group when analyzed by the phylogenetically relevant methods of multilocus enzyme electrophoresis (MLEE) (72) and multilocus sequence typing (MLST) (45). The genome of serotype Typhi CT18 is predicted to contain more than 4,000 coding sequences and 204 pseudogenes. These are largely conserved in the second sequenced isolate serotype Typhi Ty2 (21), which supports the idea that genome degradation has contributed to the host restriction of serotype Typhi (62). When serotype Typhi became isolated in the human host the function of genes required for survival in other hosts could have been lost in the absence of selective pressure. The gain of host adaptation, the ability to cause invasive disease, may also be the result of a loss of gene function. By reducing the ability to cause a secretory response in the human gut (e.g., loss of gene function on the CS54 island, see below) the invasive nature of serotype Typhi infection may be favored. The acquisition of DNA has also played an important role in the evolution of salmonellae (46). The most noticeable genetic addition in serotype Typhi, when compared with other salmonellae, is the presence of Salmonella pathogenicity island 7 (SPI-7) (87). This island contains the genes responsible for the synthesis and transport of the Vi capsular polysaccharide (termed the viaB region) (34), the SPI-1 type III secretion system (TTSS) effector protein sopE (33), and the pil genes that encode a type IVB pilus implicated in bacterial self-association (58, 80) and interactions with epithelial cells (95). SPI-7 is present in a very similar form in serotype Paratyphi C and some isolates of serotype Dublin (64). Subtle differences may, however, affect the properties encoded by regions of the island, for example, serotype Paratyphi C, unlike serotype Typhi, can not self-associate via the products of the pil region. This is because sequence variations in the repeat regions flanking the serotype Paratyphi C shufflon cause the shufflon to be inactive, resulting in the stable production of PilV, a potential minor pilus protein that has been shown to have a negative effect on the self-association of serotype Typhi (76). The importance of pil-mediated serotype Typhi self-association in the pathogenesis of typhoid fever has yet to be demonstrated, although transfer of conjugative plasmids in vitro is enhanced by the ability to self-associate (58). Serotype Typhi CT18 has a unique repertoire of eight fimbrial operons (79). These are all present in various combinations with other fimbrial operons in several salmonellae and a simple correlation between fimbrial operons and host specificity, or disease syndrome, has not been demonstrated. Serotype Typhimurium LT2 has 13 fimbrial operons (55) and it is possible that a lack of fimbrae is associated with host restriction because of the increased need for immune evasion associated with dependence on a single host. Certainly of the human restricted salmonellae none possess the same major lipopolysaccharide (LPS) group. A fact interpreted as showing that the host immune response to the major serogroups (O-antigen epitopes) selects against less transmissible host restricted S. enterica of the same serotype (83) (Table 3). This may also explain the variation in fimbriae expressed by different serotypes. In serotype Paratyphi A SopE from the serotype Typhi specific SPI-7 is present, but not in the same site as in serotype Typhi, while the rest of SPI-7 is entirely absent (64). SPI-7 can be missing from serotype Typhi in culture collections (59), but it is almost always present in fresh clinical isolates (88). This suggests that SPI-7 plays an important role during the infective process. The absence of most of SPI-7 from serotype Paratyphi A, which causes a very similar disease to typhoid in humans (see below), is therefore of interest. A H-NS-regulated cytotoxin is one virulence factor shared by, and apparently restricted to, serotype Paratyphi A and serotype Typhi, the expression of which is enhanced in the serotype Typhi vaccine strain Ty21a (61).
Serotype Paratyphi A is the second most common cause of enteric fever. The number of reported cases in several Asian countries is currently on the increase, although the risk factors for acquiring serotype Paratyphi A may differ from those for typhoid fever (85). This suggests that, even if the pathogenicity of serotype Typhi and serotype Paratyphi A are very similar, there may be some differences in transmission routes.
The type III secretion systems, SPI-1 and SPI-2, are intact in both serotype Typhi and serotype Paratyphi A, although some of the effector proteins (spoA, sopD2, sseJ, and slrP) are predicted to be pseudogenes in both serotypes, but once again the significance of this is unknown. One effector protein, SopE, is present in both serotype Typhi and serotype Paratyphi and in only some epidemic strains of serotype Typhimurium (25). This protein is very closely related to SopE2, which is intact in serotype Paratyphi A but present as a pseudogene in serotype Typhi. SopE would, therefore, seem to be worthy of further investigation.
Serotype Typhi and serotype Paratyphi A are both restricted to humans, whereas the serotype Paratyphi B group is more like the NTS in causing a range of infections in both humans and animals. In most clinical microbiology laboratories Salmonella with the serotype O4:Hb:1,2 isolated from the blood of patients with suspected enteric fever would be typed as serotype Paratyphi B. Salmonella with this serotype, however, are more frequently isolated from the stools of patients with gastroenteritis. The ability to ferment d-tartrate (dT) has become the diagnostic method to distinguish between the enteric fever serotype Paratyphi B, which does not ferment d-tartrate (dT–), and the NTS-like serotype Paratyphi B var. java, which can ferment d-tartrate (dT+) (43). The ability to produce a slime wall has also been associated with the typhoidal strains; however, in a very detailed study of United Kingdom isolates, Chart et al. demonstrated that this distinction is not absolute and slime wall production can be the same for both dT+ and dT– strains. Furthermore dT– serotype Paratyphi B is more often associated with gastroenteritis than with enteric fever (13). Of 367 dT– serotype Paratyphi B isolates only 12.3% were isolated from blood. This suggests that although dT– serotype Paratyphi B is more invasive than serotype Paratyphi B var. java (1.3% of 1,007 cases), it is much less invasive than serotype Typhi or serotype Paratyphi A. Chart also noted that the patients with invasive disease had a history of travel and suggested that there may be an invasive strain of serotype Paratyphi B circulating in Asia which could be adapted to the human host. This observation, that serotype Paratyphi B is heterogeneous genetically, could explain the apparent low invasiveness index of SPB as a group. Pulsed-field gel electrophoresis (PFGE) has been used to distinguish between serotype Paratyphi B and serotype Paratyphi B var. java, but it could not discriminate between invasive and noninvasive isolates in Malaysia (26). However, another study, using a comprehensive German reference collection, has shown an association between certain chromosomal digest patterns and an ability to cause invasive disease (65). Characterization of the serotype Paratyphi B group by MLEE has revealed 23 electrophoretotypes (ETs) (71). All dT– strains fall into a single ET, known as Pb1, whereas dT+ strains are found in all ETs. The restriction of dT– strains to a single phylogenetic group underlines the importance of this discriminatory test. Tartrate metabolism in E. coli has been described in detail (66). Metabolism is oxygen sensitive and depends on two genes, ttdA and ttdB, which have orthologues in Salmonella; annotated as STM3355 and STM3354 in the serotype Typhimurium LT2 sequence, and STY3535 and STY3534 in the serotype Typhi CT18 sequence. A direct link between tartrate metabolism and invasive disease is unlikely but a rapid molecular test for the recognition of the genetic lesion should allow large-scale epidemiology to be carried out. Malorny et al. (52) have performed a detailed analysis of this region of the chromosome in serotype Paratyphi B and serotype Paratyphi B var. java and have described a point mutation in the putative start codon of an adjacent possible membrane transport protein STM3356 which correlates perfectly with the dT– phenotype. This suggests that the protein may be essential for tartrate metabolism, although the function of this protein remains unknown. Within the sequence around the putative coding sequence (CDS) STM3356 there are several possible start codons, and in the annotation for serotype Typhi CT18 (STY3536) one such alternative is chosen. The biological significance of the single-base-pair difference in this CDS has yet to be determined. Given that serotype Paratyphi B strains from the MLEE group Pb1 are more often associated with gastroenteritis, even though the group contains strains that cause systemic disease, it seems likely that the ability to use tartrate has phylogenetic, but not necessarily biological, relevance. It is probable that there are invasive and noninvasive variants within the SPB Pb1 clonal group of salmonellae. The analysis of very closely related strains from a single MLEE group (Pb1) of S. enterica, which have totally different disease characteristics in the human host, such as the invasive and noninvasive strains of serotype Paratyphi B, may greatly facilitate the identification of a set of genes required for invasion across the human gut, invasion of the deeper tissues, and/or systemic dissemination and survival. So far comparisons of these two sets of isolates have revealed no differences in siderophores, serum resistance or surface structures (13), but invasive strains do possess a bacteriophage-encoded sopE, lack avrA, and have normal levels of SopB, but not SopD, production (65). Within the SPB serotype, strains adapted to poultry have been described (84), and there is extensive literature on human infection. This heterogeneous group of organisms should provide a fruitful area for the investigation of host adaptation in salmonellae.
Serotype Typhisuis is a typical host-restricted serotype that is rarely isolated from humans. Infection in pigs, the natural host, ranges from enterocolitis (67) to chronic paratyphoid fever (81). Serotype Typhisuis is auxotrophic and forms a monophyletic group by MLEE (8, 72). Differentiation from serotype Paratyphi C is based on the prototrophic nature of the latter. The use of fermentation tests for utilization of arabinose and trehalose have been described (82). By using MLEE, two distinct groups of serotype Paratyphi C have been described, one of which is closely related to serotype Typhisuis and the other to serotype Miami (72) or serotype Montevideo (8). With the serotype Paratyphi C strains SARB48 and SARB49, it appears that the two MLEE groups can also be differentiated by ribotyping (82) and MLST, suggesting that they represent distinct phylogenetic groups. Extensive analyses of serotype Paratyphi C have been carried out with PFGE (41) and ribotyping (82), but an association between strain type and difference in disease has not been described. Sequencing of a serotype Paratyphi C isolate is under way.
The third member of this serotype, serotype Choleraesuis, is a more diverse group of organisms containing three biotypes and five MLEE groups (8, 72). Serotype Choleraesuis is a host-adapted, but not restricted, serotype that causes swine paratyphoid fever (16). It causes a highly invasive disease in humans with little involvement of the gastrointestinal tract (19). The genome sequencing of serotype Choleraesuis strain SC-B67 and its two plasmids (pSCV50 and pSC138) was recently completed at Chang Gung University, Taiwan, and analysis is under way (www.salmonella.org).
In both the developed and less-developed countries serotype Enteritidis, in particular, Phage Type 4 (PT4), and serotype Typhimurium infection are the most commonly reported cause of EI NTS (9, 42). These systemic infections are most frequently seen in individuals with predisposing factors (9, 20, 32, 69, 86, 89), but bacterial factors include plasmid-borne multidrug resistance (MDR) to three or more antimicrobial agents (42) and chromosomally mediated quinolone resistance (35). Many NTS serotypes, including serotype Typhimurium and serotype Enteritidis, carry a plasmid not usually associated with resistance, the virulence plasmid, which encodes the spv genes that are essential for infection in laboratory rodents. The role of the virulence plasmid in gastroenteritis and invasive disease in humans is unclear. Some reports suggest that the spv genes promote dissemination of serotype Typhimurium from the gut (24), although in vitro experiments to date have not demonstrated a role for these genes in invasion of epithelial cells (10). Harboring of a virulence plasmid may facilitate systemic virulence in some S. enterica subspecies I serotypes, but the virulence level of the enteric disease will almost certainly vary with the bacterial strain and the host involved. The study of spv-containing pathogens needs to be complemented with epidemiological studies to determine whether virulence plasmids are important in the pathogenesis of NTS infections in humans (24).
The natural hosts for serotype Dublin are cattle. Infections in humans are not very common, although the reported incidence of invasive NTS infection caused by serotype Dublin is increasing in the United States (86). Reports from Europe vary: serotype Dublin has been reported in the United Kingdom and Denmark (49, 51, 77), but it does not seem to be a problem in Spain with no cases of serotype Dublin being reported among the 970 Salmonella isolates from humans collected between 1991 and 1996 (68). Also in Australia between 1995 and 2003, serotype Dublin has not been reported in humans although it is very common in cattle (surveillance reports from the National Enteric Pathogen Surveillance Scheme [NEPSS], Melbourne University, Victoria, Australia). There are few, if any reports of invasive cases of serotype Dublin being reported from Africa and Asia. Whether this patchy distribution of human cases is because of human factors, food animals, or variation in the bacterial population has not been studied in depth. Variation in the bacterial population has been demonstrated; by using MLEE, serotype Dublin can be divided into three clonal types that are very closely related to serotype Enteritidis (73). Though both serotypes are similar at the genetic level, serotype Dublin is largely host adapted for cattle and serotype Enteritidis has a wider range of hosts, with the strongest association with poultry and humans. Geographical differences also occur; type Du1 is globally distributed, whereas Du3 is restricted to France and the United Kingdom and contains all the capsulate strains (Vi positive) (73). The epidemiological data linking bacterial variation and human disease is limited but there is an association between ribotype and the ability of serotype Dublin to cause human invasive disease (17), and with strain type when using a combination of plasmid profiles, ribotyping, and PFGE (51). The data taken together suggest that some serotype Dublin strains may be more infectious for humans. Which genetic factors may be responsible for this has also been investigated. Vi-positive strains contain the SPI-7 type IV pili, used by Typhi for self-association (64). Disruption of this system reduces invasion across human cultured intestinal cells (57). Serotype Dublin also carries an spv-containing plasmid, which promotes enhanced intracellular proliferation in intestinal tissues and at extraintestinal sites in the natural host, cattle (50); however, no association has been found with human disease (17, 60).
Serotype Dublin therefore seems to be a polyphyletic serotype with two main clonal groups. One of these groups contains strains that are Vi positive and may be associated with the ability to cause invasive disease in humans.
There have been numerous single-case reports of invasive serotype Virchow infections (5, 6, 78); this serotype is recognized as a significant cause of invasive salmonellosis in Israel (74, 90), Australia (1, 4), and the United Kingdom (78, 91). The increasing incidence of serotype Virchow PT26 is of particular concern because of its association with more invasive disease in humans (75, 92). In contrast to the United Kingdom and Australia, there have been no reports of invasive serotype Virchow infections from North America (44, 86) and this serotype was not mentioned among CDCs ten most frequently reported Salmonella from humans (Salmonella surveillance summary for 1986, CDC 1988). Little is known about the population structure of this serotype, but it can infect animals and seems to cause invasive disease in humans.
Serotype Panama and serotype London infection in Liverpool, United Kingdom, have a high invasive index (91) and in Taiwan the majority of cases of bacteremia involving serotype Panama (79.5%) occur in children without predisposing conditions (94). Bacteremia due to serotype Heidelberg has been reported from the Unites States (77, 86) and Australia (NEPSS 2001–2003). It can be egg associated (36), and has an invasiveness index of 11% (60 of 551 serotype Heidelberg isolated were from invasive disease) was higher than that for serotype Typhimurium (6%) and serotype Enteritidis (6%) (86). However, the high blood invasion index for serotype Heidelberg is not consistent in different countries; 3.3% in the United Kingdom and 5.9% from Australia. Limited data on the population structure of this serotype suggest that it is monophyletic (8). In a study carried out in New Zealand, of a total of 62 cases of salmonellosis, 30 were culture-positive for serotype Brandenburg (48%). Of these cases, 13 (43%) were from extraintestinal sites. Eleven of these 13 (85%) cases did not have any risk factors for invasive disease (18). Serotype Schwarzengrund represented 11 (2%) of the 540 culture-confirmed invasive Salmonella infections identified by FoodNet in a surveillance carried out between 1996 and 1999 in the United States (86). Of 192 serotype Bredeney cases in Eastern Australia, noted in a report by NEPSS for the year 1995, 17 (9%) were invasive. In 2002 in Australia 178 cases of serotype Chester were reported, of which 7 (3.9%) were invasive, and 219 cases were reported in 2003, of which 10 (4.6%) were invasive (NEPSS 2001–2003).
For serotype Typhi and serotype Paratyphi A there is a clear association between serotype and systemic infection in humans. Comparisons made between sequenced strains of serotype Typhi and serotype Paratyphi A and microarray data investigating regions of intraserotype variation for serotype Typhi (7) and serotype Paratyphi A (54) have begun to shed light on genetic factors that are important to the ability of these related but distinct serotypes restricted to humans to cause systemic disease. The acquisition of islands of DNA or single genes may explain, in part, why these two serotypes are adapted to humans, but the presence of an overlapping, but not identical, set of pseudogenes caused by different mutational lesions suggests convergent evolution and genome degradation as part of adaptation to a common niche (54). Which of the many pseudogenes or regions of acquired sequence have contributed to the host restriction of both serotype Typhi and serotype Paratyphi A and/or to their ability to cause systemic disease in the human host remains to be discovered. For serotypes Paratyphi B and Paratyphi C, a good clinical description of the host and a detailed population of genetics of the pathogen are necessary before more detailed genetic studies of novel virulence factors can be initiated.
Serotype Typhimurium and serotype Enteritidis are the most common serotypes within the food chain and thus the high number of invasive infections associated with these serotypes is most likely due to exposure rather than to increased virulence of the pathogen. In Africa, however, a closely related group of strains of serotype Typhimurium may have become host adapted to humans (31). Some of the NTS associated with human invasive disease are not single clonal groups (81) and again a more detailed molecular analysis of the pathogen will be necessary before we can effectively search for bacterial virulence factors. The similarities between serotypes such as serotype Typhi and serotype Typhimurium suggest that they share some mechanisms for invasion and intracellular trafficking (56); however, it is also clear that salmonellae exhibit diversity in their mechanism of adaptation even to a single host, human beings (81).
References
1. Ashdown, L. R., and P. J. Ryan. 1990. Invasive disease due to Salmonella virchow: a north Queensland problem. Med. J. Aust. 153(6):330-2, 334-5.[Search PubMed for this reference]
2. Barker, R. M. 1985. Utilization of d-tartaric acid by Salmonella paratyphi B and Salmonella java: comparison of anaerobic plate test, lead acetate test and turbidity test. J. Hyg. (London) 95:107–114.[Search PubMed for this reference]
3. Benenson, S., D. Raveh, Y. Schlesinger, J. Alberton, B. Rudensky, I. Hadas-Halpern, and A. M. Yinnon. 2001. The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia. Am. J. Med. 110:60–63.[Search PubMed for this reference]
4. Bennett, C. M., C. Dalton, M. Beers-Deeble, A. Milazzo, E. Kraa, D. Davos, M. Puech, A. Tan, and M. W. Heuzenroeder. 2003. Fresh garlic: a possible vehicle for Salmonella virchow. Epidemiol. Infect. 131:1041–1048.[Search PubMed for this reference]
5. Billingham, J. D., and M. P. Slack. 1981. Cholecystitis and subphrenic abscess caused by Salmonella virchow. Postgrad. Med. J. 57:308–309.[Search PubMed for this reference]
6. Bitsori, M., E. Galanakis, S. Maraki, M. Raissaki, E. Velivassakis, and S. Sbyrakis. 2001. Invasive Salmonella virchow infection in childhood. Scand. J. Infect. Dis. 33:862–865.[Search PubMed for this reference]
7. Boyd, E. F., S. Porwollik, F. Blackmer, and M. McClelland. 2003. Differences in gene content among Salmonella enterica serovar typhi isolates. J. Clin. Microbiol. 41:3823–3828.[Search PubMed for this reference]
8. Boyd, E. F., F. S. Wang, P. Beltran, S. A. Plock, K. Nelson, and R. K. Selander. 1993. Salmonella reference collection B (SARB): strains of 37 serovars of subspecies I. J. Gen. Microbiol. 139(Pt 6):1125–1132.[Search PubMed for this reference]
9. Brown, M., and S. J. Eykyn. 2000. Non-typhoidal Salmonella bacteraemia without gastroenteritis: a marker of underlying immunosuppression. Review of cases at St. Thomas' Hospital 1970–1999. J. Infect. 41:256–259.[Search PubMed for this reference]
10. Bukholm, G., and K. J. Figenschau. 1988. Invasiveness of enterobacteria related to the presence of high molecular weight plasmids. APMIS 96:30–96.[Search PubMed for this reference]
11. Butler, T., J. Knight, S. K. Nath, P. Speelman, S. K. Roy, and M. A. Azad. 1985. Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Rev. Infect. Dis. 7:244–256.[Search PubMed for this reference]
12. Chanh, N. Q., P. Everest, T. Tan Khoa, D. House, S. Murch, C. Parry, P. Connerton, P. V. Bay, T. S. Diep, P. Mastroeni, N. J. White, T. T. Hien, V. Van Ho, G. Dougan, J. J. Farrar, and J. Wain. 2004. A clinical, microbiological, and pathological study of intestinal perforation associated with typhoid fever. Clin. Infect. Dis. 39:61–67.[Search PubMed for this reference]
13. Chart, H. 2003. The pathogenicity of strains of Salmonella paratyphi B and Salmonella java. J. Appl. Microbiol. 94:340–348.[Search PubMed for this reference]
14. Cheesbrough, J. S., B. C. Taxman, S. D. Green, F. I. Mewa, and A. Numbi. 1997. Clinical definition for invasive Salmonella infection in African children. Pediatr. Infect. Dis. J. 16:277–283.[Search PubMed for this reference]
15. Chierakul, W., A. Rajanuwong, V. Wuthiekanun, N. Teerawattanasook, M. Gasiprong, A. Simpson, W. Chaowagul, and N. J. White. 2004. The changing pattern of bloodstream infections associated with the rise in HIV prevalence in northeastern Thailand. Trans. R. Soc. Trop. Med. Hyg. 98:678–686.[Search PubMed for this reference]
16. Chiu, C. H., L. H. Su, and C. Chu. 2004. Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment. Clin. Microbiol. Rev. 17:311–322.[Search PubMed for this reference]
17. Chowdry, N., E. J. Threlfall, B. Rowe, and J. Stanley. 1993. Genotype analysis of faecal and blood isolates of Salmonella dublin from humans in England and Wales. Epidemiol. Infect. 110:217–225.[Search PubMed for this reference]
18. Clarke, R., and P. Tomlinson. 2004. Salmonella Brandenburg: changing patterns of disease in Southland Province, New Zealand. N. Z. Med. J. 117:U1144.[Search PubMed for this reference]
19. Cohen, J. I., J. A. Bartlett, and G. R. Corey. 1987. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore) 66:349–388.[Search PubMed for this reference]
20. Communicable Disease Surveillance Centre (CDSC). 2000. Trends in selected gastrointestinal infections; 1999. Commun. Dis. Rep. CDR Wkly. 10:9–12.[Search PubMed for this reference]
21. Deng, W., S. R. Liou, G. Plunkett III, G. F. Mayhew, D. J. Rose, V. Burland, V. Kodoyianni, D. C. Schwartz, and F. R. Blattner. 2003. Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J. Bacteriol. 185:2330–2337.[Search PubMed for this reference]
22. Dowling, J. J., C. J. Whitty, M. Chaponda, C. Munthali, E. E. Zijlstra, C. F. Gilks, S. B. Squire, and M. A. Gordon. 2002. Are intestinal helminths a risk factor for non-typhoidal Salmonella bacteraemia in adults in Africa who are seropositive for HIV? A case-control study. Ann. Trop. Med. Parasitol. 96:203–208.[Search PubMed for this reference]
23. Everest, P., J. Wain, M. Roberts, G. Rook, and G. Dougan. 2001. The molecular mechanisms of severe typhoid fever. Trends Microbiol. 9:316–320.[Search PubMed for this reference]
24. Fierer, J. 2001. Extra-intestinal Salmonella infections: the significance of spv genes. Clin. Infect. Dis. 32:519–520.[Search PubMed for this reference]
25. Friebel, A., H. Ilchmann, M. Aepfelbacher, K. Ehrbar, W. Machleidt, and W. D. Hardt. 2001. SopE and SopE2 from Salmonella typhimurium activate different sets of RhoGTPases of the host cell. J. Biol. Chem. 276:34035–34040.[Search PubMed for this reference]
26. Goh, Y. L., R. Yasin, S. D. Puthucheary, Y. T. Koh, V. K. Lim, Z. Taib, and K. L. Thong. 2003. DNA fingerprinting of human isolates of Salmonella enterica serotype Paratyphi B in Malaysia. J. Appl. Microbiol. 95:1134–1142.[Search PubMed for this reference]
27. Gordon, M. A., H. T. Banda, M. Gondwe, S. B. Gordon, M. J. Boeree, A. L. Walsh, J. E. Corkill, C. A. Hart, C. F. Gilks, and M. E. Molyneux. 2002. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 16:1633–1641.[Search PubMed for this reference]
28. Gordon, M. A., A. L. Walsh, M. Chaponda, D. Soko, M. Mbvwinji, M. E. Molyneux, and S. B. Gordon. 2001. Bacteraemia and mortality among adult medical admissions in Malawi—predominance of non-typhi salmonellae and Streptococcus pneumoniae. J. Infect. 42:44–49.[Search PubMed for this reference]
29. Gotuzzo, E., O. Frisancho, J. Sanchez, G. Liendo, C. Carrillo, R. E. Black, and J. G. Morris, Jr. 1991. Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or Salmonella paratyphi in an endemic typhoid area. Arch. Intern. Med. 151:381–132.[Search PubMed for this reference]
30. Graham, S. M., C. A. Hart, E. M. Molyneux, A. L. Walsh, and M. E. Molyneux. 2000. Malaria and Salmonella infections: cause or coincidence? Trans. R. Soc. Trop. Med. Hyg. 94:227.[Search PubMed for this reference]
31. Graham, S. M., E. M. Molyneux, A. L. Walsh, J. S. Cheesbrough, M. E. Molyneux, and C. A. Hart. 2000. Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr. Infect. Dis. J. 19:1189–1196.[Search PubMed for this reference]
32. Graham, S. M., A. L. Walsh, E. M. Molyneux, A. J. Phiri, and M. E. Molyneux. 2000. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans. R. Soc. Trop. Med. Hyg. 94:310–314.[Search PubMed for this reference]
33. Hardt, W. D., H. Urlaub, and J. E. Galan. 1998. A substrate of the centisome 63 type III protein secretion system of Salmonella typhimurium is encoded by a cryptic bacteriophage. Proc. Natl. Acad. Sci. USA 95:2574–2579.[Search PubMed for this reference]
34. Hashimoto, Y., N. Li, H. Yokoyama, and T. Ezaki. 1993. Complete nucleotide sequence and molecular characterization of ViaB region encoding Vi antigen in Salmonella typhi. J. Bacteriol. 175:4456–4465.[Search PubMed for this reference]
35. Helms, M., J. Simonsen, and K. Molbak. 2004. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J. Infect. Dis. 190:1652–1654.[Search PubMed for this reference]
36. Hennessy, T. W., L. H. Cheng, H. Kassenborg, S. D. Ahuja, J. Mohle-Boetani, R. Marcus, B. Shiferaw, and F. J. Angulo. 2004. Egg consumption is the principal risk factor for sporadic Salmonella serotype Heidelberg infections: a case-control study in FoodNet sites. Clin. Infect. Dis. 38(Suppl. 3):S237–S243.[Search PubMed for this reference]
36a. Hopkins, K. L., and E. J. Threlfall. 2004. Frequency and polymorphism of sopE in isolates of Salmonella enterica belonging to the ten most prevalent serotypes in England and Wales. J. Med. Microbiol. 53:539–543.[Search PubMed for this reference]
37. House, D., A. Bishop, C. Parry, G. Dougan, and J. Wain. 2001. Typhoid fever: pathogenesis and disease. Curr. Opin. Infect. Dis. 14:573–578.[Search PubMed for this reference]
38. Hsu, R. B., Y. G. Tsay, R. J. Chen, and S. H. Chu. 2003. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin. Infect. Dis. 36:829–834.[Search PubMed for this reference]
39. Ispahani, P., and R. C. Slack. 2000. Enteric fever and other extraintestinal salmonellosis in University Hospital, Nottingham, UK, between 1980 and 1997. Eur. J. Clin. Microbiol. Infect. Dis. 19:679–687.[Search PubMed for this reference]
40. Kains, J. P., J. P. Dereume, F. Jacobs, J. C. Legrand, J. C. Wautrecht, and J. P. Thys. 1987. Salmonella endarteritis, about two cases and their management. J. Cardiovasc. Surg. (Torino) 28:538–541.[Search PubMed for this reference]
41. Kariuki, S., J. Cheesbrough, A. K. Mavridis, and C. A. Hart. 1999. Typing of Salmonella enterica serotype paratyphi C isolates from various countries by plasmid profiles and pulsed-field gel electrophoresis. J. Clin. Microbiol. 37:2058–2060.[Search PubMed for this reference]
42. Kariuki, S., G. Revathi, N. Kariuki, J. Muyodi, J. Mwituria, A. Munyalo, D. Kagendo, L. Murungi, and C. Anthony Hart. 2005. Increasing prevalence of multidrug-resistant non-typhoidal salmonellae, Kenya, 1994–2003. Int. J. Antimicrob. Agents 25:38–43.[Search PubMed for this reference]
43. Kauffmann, F. 1955. [Differential diagnosis and pathogenicity of Salmonella java and Salmonella paratyphi B.]. Z. Hyg. Infektionskr. 141:546–550.[Search PubMed for this reference]
44. Khakhria, R., D. Woodward, W. M. Johnson, and C. Poppe. 1997. Salmonella isolated from humans, animals and other sources in Canada, 1983–92. Epidemiol. Infect. 119:15–23.[Search PubMed for this reference]
45. Kidgell, C., U. Reichard, J. Wain, B. Linz, M. Torpdahl, G. Dougan, and M. Achtman. 2002. Salmonella typhi, the causative agent of typhoid fever, is approximately 50,000 years old. Infect. Genet. Evol. 2:39–45.[Search PubMed for this reference]
46. Kingsley, R. A., and A. J. Baumler. 2000. Host adaptation and the emergence of infectious disease: the Salmonella paradigm. Mol. Microbiol. 36:1006–1014.[Search PubMed for this reference]
47. Kingsley, R. A., A. D. Humphries, E. H. Weening, M. R. De Zoete, S. Winter, A. Papaconstantinopoulou, G. Dougan, and A. J. Baumler. 2003. Molecular and phenotypic analysis of the CS54 island of Salmonella enterica serotype Typhimurium: identification of intestinal colonization and persistence determinants. Infect. Immun. 71:629–640.[Search PubMed for this reference]
48. Kingsley, R. A., A. M. Keestra, M. R. de Zoete, and A. J. Baumler. 2004. The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding. Mol. Microbiol. 52:345–355.[Search PubMed for this reference]
49. Lester, A., N. H. Eriksen, H. Nielsen, P. B. Nielsen, A. Friis-Moller, B. Bruun, J. Scheibel, K. Gaarslev, and H. J. Kolmos. 1991. Non-typhoid Salmonella bacteraemia in Greater Copenhagen 1984 to 1988. Eur. J. Clin. Microbiol. Infect. Dis. 10:486–490.[Search PubMed for this reference]
50. Libby, S. J., L. G. Adams, T. A. Ficht, C. Allen, H. A. Whitford, N. A. Buchmeier, S. Bossie, and D. G. Guiney. 1997. The spv genes on the Salmonella dublin virulence plasmid are required for severe enteritis and systemic infection in the natural host. Infect. Immun. 65:1786–1792.[Search PubMed for this reference]
51. Liebana, E., L. Garcia-Migura, C. Clouting, C. A. Cassar, F. A. Clifton-Hadley, E. A. Lindsay, E. J. Threlfall, S. A. Chappell, and R. H. Davies. 2002. Investigation of the genetic diversity among isolates of Salmonella enterica serovar Dublin from animals and humans from England, Wales and Ireland. J. Appl. Microbiol. 93:732–744.[Search PubMed for this reference]
52. Malorny, B., C. Bunge, and R. Helmuth. 2003. Discrimination of d-tartrate-fermenting and -nonfermenting Salmonella enterica subsp. enterica isolates by genotypic and phenotypic methods. J. Clin. Microbiol. 41:4292–4297.[Search PubMed for this reference]
53. Manfredi, R., C. Donzelli, S. Talo, S. M. Guzman, and F. Chiodo. 1998. Typhoid fever and HIV infection: a rare disease association in industrialized countries. Int. J. Infect. Dis. 3:105–108.[Search PubMed for this reference]
54. McClelland, M., K. E. Sanderson, S. W. Clifton, P. Latreille, S. Porwollik, A. Sabo, R. Meyer, T. Bieri, P. Ozersky, M. McLellan, C. R. Harkins, C. Wang, C. Nguyen, A. Berghoff, G. Elliott, S. Kohlberg, C. Strong, F. Du, J. Carter, C. Kremizki, D. Layman, S. Leonard, H. Sun, L. Fulton, W. Nash, T. Miner, P. Minx, K. Delehaunty, C. Fronick, V. Magrini, M. Nhan, W. Warren, L. Florea, J. Spieth, and R. K. Wilson. 2004. Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat. Genet. 36:1268–1274.[Search PubMed for this reference]
55. McClelland, M., K. E. Sanderson, J. Spieth, S. W. Clifton, P. Latreille, L. Courtney, S. Porwollik, J. Ali, M. Dante, F. Du, S. Hou, D. Layman, S. Leonard, C. Nguyen, K. Scott, A. Holmes, N. Grewal, E. Mulvaney, E. Ryan, H. Sun, L. Florea, W. Miller, T. Stoneking, M. Nhan, R. Waterston, and R. K. Wilson. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852–856.[Search PubMed for this reference]
56. Mills, S. D., and B. B. Finlay. 1994. Comparison of Salmonella typhi and Salmonella typhimurium invasion, intracellular growth and localization in cultured human epithelial cells. Microb. Pathog. 17:409–423.[Search PubMed for this reference]
57. Morris, C., C. K. Tam, T. S. Wallis, P. W. Jones, and J. Hackett. 2003. Salmonella enterica serovar Dublin strains which are Vi antigen-positive use type IVB pili for bacterial self-association and human intestinal cell entry. Microb. Pathog. 35:279–284.[Search PubMed for this reference]
58. Morris, C., C. M. Yip, I. S. Tsui, D. K. Wong, and J. Hackett. 2003. The shufflon of Salmonella enterica serovar Typhi regulates type IVB pilus-mediated bacterial self-association. Infect. Immun. 71:1141–1146.[Search PubMed for this reference]
59. Nair, S., S. Alokam, S. Kothapalli, S. Porwollik, E. Proctor, C. Choy, M. McClelland, S. L. Liu, and K. E. Sanderson. 2004. Salmonella enterica serovar Typhi strains from which SPI7, a 134-kilobase island with genes for Vi exopolysaccharide and other functions, has been deleted. J. Bacteriol. 186:3214–3223.[Search PubMed for this reference]
60. Olsen, J. E., D. L. Baggesen, B. B. Nielsen, and H. E. Larsen. 1990. The prevalence of plasmids in Danish bovine and human isolates of Salmonella dublin. APMIS 98:735–740.[Search PubMed for this reference]
61. Oscarsson, J., M. Westermark, S. Lofdahl, B. Olsen, H. Palmgren, Y. Mizunoe, S. N. Wai, and B. E. Uhlin. 2002. Characterization of a pore-forming cytotoxin expressed by Salmonella enterica serovars typhi and paratyphi A. Infect. Immun. 70:5759–5769.[Search PubMed for this reference]
62. Parkhill, J., G. Dougan, K. D. James, N. R. Thomson, D. Pickard, J. Wain, C. Churcher, K. L. Mungall, S. D. Bentley, M. T. Holden, M. Sebaihia, S. Baker, D. Basham, K. Brooks, T. Chillingworth, P. Connerton, A. Cronin, P. Davis, R. M. Davies, L. Dowd, N. White, J. Farrar, T. Feltwell, N. Hamlin, A. Haque, T. T. Hien, S. Holroyd, K. Jagels, A. Krogh, T. S. Larsen, S. Leather, S. Moule, P. O'Gaora, C. Parry, M. Quail, K. Rutherford, M. Simmonds, J. Skelton, K. Stevens, S. Whitehead, and B. G. Barrell. 2001. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413:848–852.[Search PubMed for this reference]
63. Parry, C. M., T. T. Hien, G. Dougan, N. J. White, and J. J. Farrar. 2002. Typhoid fever. N. Engl. J. Med. 347:1770–1782.[Search PubMed for this reference]
64. Pickard, D., J. Wain, S. Baker, A. Line, S. Chohan, M. Fookes, A. Barron, P. O. Gaora, J. A. Chabalgoity, N. Thanky, C. Scholes, N. Thomson, M. Quail, J. Parkhill, and G. Dougan. 2003. Composition, acquisition, and distribution of the Vi exopolysaccharide-encoding Salmonella enterica pathogenicity island SPI-7. J. Bacteriol. 185:5055–5065.[Search PubMed for this reference]
65. Prager, R., W. Rabsch, W. Streckel, W. Voigt, E. Tietze, and H. Tschape. 2003. Molecular properties of Salmonella enterica serotype paratyphi B distinguish between its systemic and its enteric pathovars. J. Clin. Microbiol. 41:4270–4278.[Search PubMed for this reference]
66. Reaney, S. K., C. Begg, S. J. Bungard, and J. R. Guest. 1993. Identification of the l-tartrate dehydratase genes (ttdA and ttdB) of Escherichia coli and evolutionary relationship with the class I fumarase genes. J. Gen. Microbiol. 139:1523–1530.[Search PubMed for this reference]
67. Rodriguez-Buenfil, J. C., M. Alvarez-Fleites, Z. Y. Villarreal-Morales, and J. C. Segura-Correa. 2004. Incidence and identification of Salmonella species in pigs on two farm systems in Mexico. Vet. Rec. 154:150–152.[Search PubMed for this reference]
68. Rodriguez, M., I. de Diego, and M. C. Mendoza. 1998. Extraintestinal salmonellosis in a general hospital (1991 to 1996): relationships between Salmonella genomic groups and clinical presentations. J. Clin. Microbiol. 36:3291–3296.[Search PubMed for this reference]
69. Rodriguez, R. E., V. Valero, and C. Watanakunakorn. 1986. Salmonella focal intracranial infections: review of the world literature (1884—1984) and report of an unusual case. Rev. Infect. Dis. 8:31–41.[Search PubMed for this reference]
70. Rotger, R., and J. Casadesus. 1999. The virulence plasmids of Salmonella. Int. Microbiol. 2:177–184.[Search PubMed for this reference]
71. Selander, R. K., P. Beltran, N. H. Smith, R. M. Barker, P. B. Crichton, D. C. Old, J. M. Musser, and T. S. Whittam. 1990. Genetic population structure, clonal phylogeny, and pathogenicity of Salmonella paratyphi B. Infect. Immun. 58:1891–1901.[Search PubMed for this reference]
72. Selander, R. K., P. Beltran, N. H. Smith, R. Helmuth, F. A. Rubin, D. J. Kopecko, K. Ferris, B. D. Tall, A. Cravioto, and J. M. Musser. 1990. Evolutionary genetic relationships of clones of Salmonella serovars that cause human typhoid and other enteric fevers. Infect. Immun. 58:2262–2275.[Search PubMed for this reference]
73. Selander, R. K., N. H. Smith, J. Li, P. Beltran, K. E. Ferris, D. J. Kopecko, and F. A. Rubin. 1992. Molecular evolutionary genetics of the cattle-adapted serovar Salmonella dublin. J. Bacteriol. 174:3587–3592.[Search PubMed for this reference]
74. Shimoni, Z., S. Pitlik, L. Leibovici, Z. Samra, H. Konigsberger, M. Drucker, V. Agmon, S. Ashkenazi, and M. Weinberger. 1999. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin. Infect. Dis. 28:822–827.[Search PubMed for this reference]
75. Sullivan, A. M., L. R. Ward, B. Rowe, J. B. Woolcock, and J. M. Cox. 1998. Phage types of Australian isolates of Salmonella enterica subsp. enterica serovar Virchow. Lett. Appl. Microbiol. 27:216–218.[Search PubMed for this reference]
76. Tam, C. K. P., J. Hackett, and C. Morris. 2004. Salmonella enterica serovar Paratyphi C carries an inactive shufflon. Infect. Immun. 72:22–28.[Search PubMed for this reference]
77. Threlfall, E. J., M. L. Hall, and B. Rowe. 1992. Salmonella bacteraemia in England and Wales, 1981–1990. J. Clin. Pathol. 45:34–36.[Search PubMed for this reference]
78. Todd, W. T., and J. M. Murdoch. 1983. Salmonella virchow: a cause of significant bloodstream invasion. Scott. Med. J. 28:176–178.[Search PubMed for this reference]
79. Townsend, S. M., N. E. Kramer, R. Edwards, S. Baker, N. Hamlin, M. Simmonds, K. Stevens, S. Maloy, J. Parkhill, G. Dougan, and A. J. Baumler. 2001. Salmonella enterica serovar Typhi possesses a unique repertoire of fimbrial gene sequences. Infect. Immun. 69:2894–2901.[Search PubMed for this reference]
80. Tsui, I. S., C. M. Yip, J. Hackett, and C. Morris. 2003. The type IVB pili of Salmonella enterica serovar Typhi bind to the cystic fibrosis transmembrane conductance regulator. Infect. Immun. 71:6049–6050.[Search PubMed for this reference]
81. Uzzau, S., D. J. Brown, T. Wallis, S. Rubino, G. Leori, S. Bernard, J. Casadesus, D. J. Platt, and J. E. Olsen. 2000. Host adapted serotypes of Salmonella enterica. Epidemiol. Infect. 125:229–255.[Search PubMed for this reference]
82. Uzzau, S., M. Hovi, and B. A. Stocker. 1999. Application of ribotyping and IS200 fingerprinting to distinguish the five Salmonella serotype O6,7:c:1,5 groups: Choleraesuis sensu stricto, Choleraesuis var. Kunzendorf, Choleraesuis var. Decatur, Paratyphi C, and Typhisuis. Epidemiol. Infect. 123:37–46.[Search PubMed for this reference]
83. van der Woude, M. W., and A. J. Baumler. 2004. Phase and antigenic variation in bacteria. Clin. Microbiol. Rev. 17:581–611.[Search PubMed for this reference]
84. Van Immerseel, F., L. Meulemans, J. De Buck, F. Pasmans, P. Velge, E. Bottreau, F. Haesebrouck, and R. Ducatelle. 2004. Bacteria-host interactions of Salmonella Paratyphi B dT+ in poultry. Epidemiol. Infect. 132:239–243.[Search PubMed for this reference]
85. Vollaard, A. M., S. Ali, H. A. van Asten, S. Widjaja, L. G. Visser, C. Surjadi, and J. T. van Dissel. 2004. Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA 291:2607–2615.[Search PubMed for this reference]
86. Vugia, D. J., M. Samuel, M. M. Farley, R. Marcus, B. Shiferaw, S. Shallow, K. Smith, and F. J. Angulo. 2004. Invasive Salmonella infections in the United States, FoodNet, 1996–1999: incidence, serotype distribution, and outcome. Clin. Infect. Dis. 38(Suppl. 3):S149–S156.[Search PubMed for this reference]
87. Wain, J., D. House, J. Parkhill, C. Parry, and G. Dougan. 2002. Unlocking the genome of the human typhoid bacillus. Lancet Infect. Dis. 2:163–170.[Search PubMed for this reference]
88. Wain, J., D. House, A. Zafar, S. Baker, S. Nair, C. Kidgell, Z. Bhutta, G. Dougan, and R. Hasan. 2005. Vi antigen expression in Salmonella enterica Serovar Typhi clinical isolates from Pakistan. J. Clin. Microbiol. 43:1158–1165.[Search PubMed for this reference]
89. Walsh, A. L., E. M. Molyneux, M. Kabudula, A. J. Phiri, M. E. Molyneux, and S. M. Graham. 2002. Bacteraemia following blood transfusion in Malawian children: predominance of Salmonella. Trans. R. Soc. Trop. Med. Hyg. 96:276–277.[Search PubMed for this reference]
90. Weinberger, M., N. Andorn, V. Agmon, D. Cohen, T. Shohat, and S. D. Pitlik. 2004. Blood invasiveness of Salmonella enterica as a function of age and serotype. Epidemiol. Infect. 132:1023–1028.[Search PubMed for this reference]
91. Wilkins, E. G., and C. Roberts. 1988. Extraintestinal salmonellosis. Epidemiol. Infect. 100:361–368.[Search PubMed for this reference]
92. Willocks, L. J., D. Morgan, F. Sufi, L. R. Ward, and H. E. Patrick. 1996. Salmonella virchow PT 26 infection in England and Wales: a case control study investigating an increase in cases during 1994. Epidemiol. Infect. 117:35–41.[Search PubMed for this reference]
93. Winslow, C.-E. A., I. J. Kligler, and W. Rothberg. 1919. Studies on the classification of the colon-typhoid with special reference to their fermentative reactions. J. Bacteriol. 4:429–503.[Search PubMed for this reference]
94. Yang, Y. J., M. C. Huang, S. M. Wang, J. J. Wu, C. P. Cheng, and C. C. Liu. 2002. Analysis of risk factors for bacteremia in children with nontyphoidal Salmonella gastroenteritis. Eur. J. Clin. Microbiol. Infect. Dis. 21:290–293.[Search PubMed for this reference]
95. Zhang, X. L., I. S. Tsui, C. M. Yip, A. W. Fung, D. K. Wong, X. Dai, Y. Yang, J. Hackett, and C. Morris. 2000. Salmonella enterica serovar typhi uses type IVB pili to enter human intestinal epithelial cells. Infect. Immun. 68:3067–3073.[Search PubMed for this reference]